Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung

Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung have?

Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung has 41 citations in the OpenAlex counts ScholarIQ stores.

When was Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung published?

Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung has 2015 year in the ScholarIQ index.

What is the open-access status of Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung?

Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung has closed oa status in the ScholarIQ index.

What is the DOI of Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung?

The DOI for Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung is on the source record.

What is the PMID of Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung?

The PMID for Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung is on the source record.

What is the OpenAlex record for Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung?

The OpenAlex for Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung is on the source record.